Hyperlipidemia in chronic hepatitis C under triple therapy with boceprevir

被引：0

作者：

Mata-Marin, J. ^{[1
]}

Huerta-Garcia, G. ^{[2
]}

Manjarrez-Tellez, B. ^{[1
]}

Andrade-Fuentes, K. ^{[3
]}

Sandoval-Ramirez, J. ^{[1
]}

Martiinez-Rodriguez, M. ^{[1
]}

机构：

[1] Hosp Infectol, Mexico City, DF, Mexico

[2] Hosp Pediat Mexico City, Mexico City, DF, Mexico

[3] Hosp Especialidades Ctr Med La Raza, Mexico City, DF, Mexico

来源：

JOURNAL OF VIRAL HEPATITIS | 2014年 / 21卷

关键词：

D O I：

10.1111/jvh.12333_25

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P26

引用

页码：35 / 36

页数：4

共 50 条

[11] Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation [J].

Knapstein, Johanna ;

Galle, Peter R. ;

Zimmermann, Tim .

DIGESTIVE AND LIVER DISEASE, 2014, 46 (01) :88-89

[12] Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates [J].

Mehawej, Mireille ;

Rostaing, Lionel ;

Alric, Laurent ;

Del Bello, Arnaud ;

Izopet, Jacques ;

Kamar, Nassim .

JOURNAL OF TRANSPLANTATION, 2015, 2015

[13] Expert Opinion on Boceprevir- and Telaprevir-Based Triple Therapies of Chronic Hepatitis C [J].

Sarrazin, C. ;

Berg, T. ;

Cornberg, M. ;

Dollinger, M. ;

Ferenci, P. ;

Hinrichsen, H. ;

Klinker, H. ;

Kraus, M. ;

Manns, M. ;

Mauss, S. ;

Peck-Radosavljevic, M. ;

Schmidt, H. ;

Spengler, U. ;

Wedemeyer, H. ;

Wirth, S. ;

Zeuzem, S. .

ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2012, 50 (01) :57-72

[14] Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy [J].

Neukam, Karin ;

Munteanu, Daniela I. ;

Rivero-Juarez, Antonio ;

Lutz, Thomas ;

Fehr, Jan ;

Mandorfer, Mattias ;

Bhagani, Sanjay ;

Lopez-Cortes, Luis F. ;

Haberl, Annette ;

Stoeckle, Marcel ;

Marquez, Manuel ;

Scholten, Stefan ;

de los Santos-Gil, Ignacio ;

Mauss, Stefan ;

Rivero, Antonio ;

Collado, Antonio ;

Delgado, Marcial ;

Rockstroh, Juergen K. ;

Pineda, Juan A. .

PLOS ONE, 2015, 10 (04)

[15] BOCEPREVIR AND TELAPREVIR BASED TRIPLE THERAPY FOR CHRONIC HEPATITIS C: ON-TREATMENT EFFICACY AND IMPACT ON KIDNEY FUNCTION AND MELD SCORE [J].

Virlogeux, V. ;

Goncalves, F. ;

Pradat, P. ;

Maynard, M. ;

Hartig-Lavie, K. ;

Amiri, M. ;

Scholtes, C. ;

Andre, P. ;

Bailly, F. ;

Zoulim, F. .

JOURNAL OF HEPATOLOGY, 2013, 58 :S377-S378

[16] Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C [J].

Petta, Salvatore ;

Cabibbo, Giuseppe ;

Enea, Marco ;

Macaluso, Fabio Salvatore ;

Plaia, Antonella ;

Bruno, Raffaele ;

Gasbarrini, Antonio ;

Bruno, Savino ;

Craxi, Antonio ;

Camma, Calogero .

DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) :936-942

[17] Triple therapy for chronic hepatitis C: Practical Aspects [J].

Bakulin, I. G. ;

Kiseleva, A. V. .

TERAPEVTICHESKII ARKHIV, 2013, 85 (11) :91-99

[18] Boceprevir targets chronic hepatitis C genotype 1 [J].

不详 .

BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (09) :489-489

[19] Review of boceprevir and telaprevir for the treatment of chronic hepatitis C [J].

Wilby, Kyle J. ;

Partovi, Nilufar ;

Ford, Jo-Ann E. ;

Greanya, Erica D. ;

Yoshida, Eric M. .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (04) :205-210

[20] Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C [J].

Foote, Bryce S. ;

Spooner, Linda M. ;

Belliveau, Paul P. .

ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) :1085-1093

← 1 2 3 4 5 →